Real-world study assesses first-line anti-PD-1, IFN-α1b, and anlotinib for advanced melanoma
A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to ...
A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine